Search Results
Site Search
It delivers insights that put patients on the right pathway. It drives revenue that can bolster the financial stability of the hospital. It elevates the standards of care in the communities it serves – but only if you recognize your lab’s...
LinkedIn Login, Sign in | LinkedIn
Login to LinkedIn to keep in touch with people you know, share ideas, and build your career.
LinkedIn Login, Sign in | LinkedIn
Login to LinkedIn to keep in touch with people you know, share ideas, and build your career.
LinkedIn Login, Sign in | LinkedIn
Login to LinkedIn to keep in touch with people you know, share ideas, and build your career.
tay_sachs_and_related_disorders_diagnostic_testing_algorithm.pdf
© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. Hexosaminidase A enzyme activity is indeterminate or indicates carrier for Tay-Sachs disease (TSD) Sandhoff disease excluded MUGS is performed 2...
inflammatory-bowel-disease-diagnostic-testing-algorithm.pdf
YES <50 mcg/g <50 mcg/g Abnormal >50 mcg/g Normal ANCA present ASCA IgG and IgA absent ANCA absent ASCA IgG or IgA present ANCA absent ASCA IgG or IgA absent >120 mcg/g50-120 mcg/g NO Assessing a patient with diarrhea when differential...
LinkedIn Login, Sign in | LinkedIn
Login to LinkedIn to keep in touch with people you know, share ideas, and build your career.
congenital-disorders-of-glycosylation-algorithm.pdf
Unexplained developmental delay, multisystemic disease with or without a neurologic component, multiple unexplained abnormalities of basic laboratory resultsa ■ CDGN - consistent with type I CDG (congenital disorder of glycosylation)...
Creepy, Dreadful, Wonderful Viruses - Insights
PACE / State of FLIn this month’s “Virtual Lecture” Bobbi Pritt, M.D., shares a series of spooky tales to scare and amaze related to the discovery, characterization, and clinical presentation of notable viruses.
New tests launched in March - Insights
In March 2022, Mayo Clinic Laboratories announced eighteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
New tests launched in May - Insights
In May 2022, Mayo Clinic Laboratories announced multiple new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
TRBC1 a Useful Tool in T-Cell Flow Cytometry [Test in Focus] - Insights
Horatiu Olteanu, M.D., Ph.D., gives an overview of the updated Leukemia and Lymphoma Immunophentoyping test now including TCRBC1 available through Mayo Clinic Laboratories.
The Living Breast Biobank - Insights
This unique Mayo Clinic resource offers a novel portal into the study of gene mutations before they cause breast cancer.
Hematology Testing - Mayo Clinic Laboratories
Our comprehensive test menu has beencreated to aid in the diagnosis and treatmentselection across the full spectrum of hematologicdisorders.
New high-resolution urine drug testing profile - Insights
Bringing together advanced testing technology, unparalleled expertise, and a patient-focused approach, Mayo Clinic Laboratories’ new high-resolution urine drug testing profile, ADMPU, evaluates for 22 drug classes including alcohol,...
An inside look at the state-of-the-art supports enabling invention - Insights
A web of innovation within Mayo Clinic Laboratories links research and test development with clinical practice, enabling for some of the world’s most pioneering methodologies. Underpinning this innovation network are unique supports that...
Multiomics: A new model for identifying biomarkers to predict severe COVID-19 outcomes - Insights
In a groundbreaking study, Mayo Clinic investigators have developed a multiomic molecular method to predict clinical COVID-19 (SARS-CoV-2) outcomes better than traditional cytokines. Using a machine-learning-based prediction model, the team...
LinkedIn Login, Sign in | LinkedIn
Login to LinkedIn to keep in touch with people you know, share ideas, and build your career.
LinkedIn Login, Sign in | LinkedIn
Login to LinkedIn to keep in touch with people you know, share ideas, and build your career.
LinkedIn Login, Sign in | LinkedIn
Login to LinkedIn to keep in touch with people you know, share ideas, and build your career.
MCL Familial Mutation Testing Required Patient Information MC1235202
MCL Familial Mutation Testing Required Patient Information Complete print Familial Variant Testing Required Patient Information Reset Form Instructions accurate interpretation reporting genetic results
lysosomal_storage_disorders_diagnostic_algorithm_part_2.pdf
If deficient, MLD confirmed One of the following suspected: ■ Aspartylglucosaminuria ■ α-Mannosidosis ■ β-Mannosidosis ■ Pompe disease ■ Sandhoff disease ■ Schindler disease ■ Sialidosis ■ Galactosialidosis* ■ α-Fucosidosis* ■...
LinkedIn Login, Sign in | LinkedIn
Login to LinkedIn to keep in touch with people you know, share ideas, and build your career.
LinkedIn Login, Sign in | LinkedIn
Login to LinkedIn to keep in touch with people you know, share ideas, and build your career.
MCL Pathology Consultation Request Form MC014901
MCL Pathology Consultation Request Form Complete print Reset Form Pathology Consultation Request PATHC Pathology Consultation Client Information required Client Client Account Client
MCL Molecular Genetics Patient Information for Uniparental Disomy MC1235300
MCL Molecular Genetics Patient Information Uniparental Disomy Complete print Reset Form Molecular Genetics Uniparental Disomy Patient Information Instructions Accurate interpretation reporting genetic results
MCL Molecular Genetics SERPINA1 Gene Patient Information MC1235299
MCL Molecular Genetics SERPINA1 Gene Patient Information Complete print Reset Form Molecular Genetics SERPINA1 Gene Patient Information Instructions Accurate interpretation reporting genetic results
Dangerous Goods Training Has Moved - Insights
Update your bookmark! Dangerous Goods can now be found at https://news.mayocliniclabs.com/dangerous-goods-training/
CPT codes and LOINC update: August 2021 - Insights
The following list includes updates posted to mayocliniclabs.com during the month of August.
CPT codes and LOINC update: January 2021 - Insights
The following list includes updates posted to mayocliniclabs.com during the month of January.
CPT codes and LOINC update: February 2022 - Insights
CPT Code updates posted to mayocliniclabs.com during the month of February
Precision therapeutics - Insights
At Mayo Clinic Laboratories, utilization of precision therapeutics, or pharmacogenomic testing used in conjunction with therapeutic drug monitoring, provides personalized insights to guide and monitor prescription medication use.
Bile acid malabsorption - Insights
Chronic diarrhea and abdominal pain can be caused by many conditions, including inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), Celiac disease, infectious GI pathogens, and malignancy. When other causes of chronic diarrhea...
Find out how our hereditary cancer panels use next-generation sequencing to evaluate dozens of genes associated with cancer risk.
December 2022 - Bone and Soft Tissue - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Bone and Soft Tissue Pathology.
This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. This case sub-specialty is Renal.
February 2020 - Laboratory Genetics & Genomics - Insights
A 71 yr old female with a history of a central nervous system lymphoma, an allogenic stem cell transplant and graft versus host disease was tested for
Learn more about how Mayo Clinic Laboratories’ test offerings and services can help hospital laboratories enhance patient care and laboratory performance.
MCL UGT1A1 Gene Testing Patient Information MC1235165
MCL UGT1A1 Gene Testing Patient Information Complete print UGT1A1 Gene Testing Patient Information Reset Form Instructions accurate interpretation reporting genetic results
MCL Metabolic Hematology Patient Information MC1235251
MCL Metabolic Hematology Patient Information Complete print Reset Form Metabolic Hematology Patient Information Instructions information requested important interpretation test
Check out Mayo Clinic Laboratories’ expert-developed biochemical and molecular testing to confirm a diagnosis of oligosaccharidosis.
Epic journey yields unique offering - Insights
The quest to create a test pinpointing the source of the rare, testicular cancer-associated illness successfully concluded in the summer of 2021.
Cross-laboratory collaboration accelerates gold-standard SRA testing - Insights
Utilizing testing capabilities of two separate laboratory facilities, Mayo Clinic Laboratories’ new serotonin release assay (SRA) is a gold-standard test supported by decades of clinical hematopathologic experience and advanced mass...
Newborn Screen Follow-up for Severe Combined Immunodeficiency Syndrome (SCID) [Algorithm] - Insights
The algorithm can be viewed here.
PathWays Case Studies: Nov. 2018 - Insights
Mayo Clinic laboratory experts share three case studies in this month’s “PathWays” post and are challenging you to test your Clinical Pathology, Molecular Diagnostic, Hematopathology, and Dermatology pathology knowledge. Review the cases,...
lysosomal_storage_disorders_diagnostic_algorithm__part_1.pdf
Order: IDUAW / Alpha-L-Iduronidase, Leukocytes Order 1 of the following: ■ BGA / Beta-Galactosidase, Leukocytes ■ MPS4B ■ MPS4W Order: FUCW / Alpha-Fucosidase, Leukocytes Order 1 of the following: MPS4W / Mucopolysaccharidosis IV Enzyme...
lysosomal-disorders-diagnostic-algorithm-part2.pdf
If deficient, MLD confirmed One of the following suspected: ■ Aspartylglucosaminuria ■ α-Mannosidosis ■ β-Mannosidosis ■ Pompe disease ■ Sandhoff disease ■ Schindler disease ■ Sialidosis1 ■ Galactosialidosis1,2 ■ α-Fucosidosis2 ■...
New tests launched in October - Insights
In October 2022, Mayo Clinic Laboratories announced thirty new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Outreach & Business Solutions - Insights
Mayo Clinic Laboratories’ Outreach Program equips laboratory leaders with Mayo Clinic expertise and customized strategies to help grow laboratory revenues by increasing efficiencies and minimizing waste.
Inborn errors of metabolism - Insights
Learn more about how Mayo Clinic Laboratories’ comprehensive menu of biochemical and molecular testing can diagnose inborn errors of metabolism.